GAIN THERAPEUTICS, INC
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -57.7% | -51.7% | -37.3% |
| FY2021 | -39.9% | -39.2% | -35.6% |
| FY2022 | -93.2% | -90.8% | -73.0% |
| FY2023 | -177.0% | -170.9% | -119.7% |
| FY2024 | -278.1% | -266.2% | -168.4% |
| FY2025 | -108.6% | -106.9% | -88.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -57.7% | -51.7% | -37.3% |
| FY2021 | -39.9% | -39.2% | -35.6% |
| FY2022 | -93.2% | -90.8% | -73.0% |
| FY2023 | -177.0% | -170.9% | -119.7% |
| FY2024 | -278.1% | -266.2% | -168.4% |
| FY2025 | -108.6% | -106.9% | -88.4% |